Serum testosterone concentrations are not associated with frailty in naturally ageing and testosterone-deficient older C57Bl/6 mice

Stefan D. Heinze-Milne; Shubham Banga; Judith Godin; Susan E. Howlett

doi:10.1016/j.mad.2022.111638

Serum testosterone concentrations are not associated with frailty in naturally ageing and testosterone-deficient older C57Bl/6 mice

Stefan D. Heinze-Milne, Shubham Banga, Judith Godin, Susan E. Howlett

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Abstract

This study investigated how serum testosterone related to frailty in ageing male C57Bl/6 mice with or without lifelong testosterone deficiency. Mice underwent a sham surgery (n = 10) or gonadectomy (n = 11, GDX) at 4-weeks and then aged. Frailty scores (31-item frailty index) and testosterone were measured between 18- to 24-months of age. Age predicted frailty (p < 0.0001), but serum testosterone did not (p = 0.357). Life expectancy (AFRAID clock) and biologic age (FRIGHT clock) were not significantly different between groups (p = 0.485 and 0.142). The fact that lifelong testosterone deficiency did not exacerbate frailty suggests that low testosterone alone does not potently drive frailty in males.

Original language	English
Article number	111638
Journal	Mechanisms of Ageing and Development
Volume	203
DOIs	https://doi.org/10.1016/j.mad.2022.111638
Publication status	Published - Apr 2022
Externally published	Yes

Bibliographical note

Funding Information:
The authors thank Peter Nicholl for his expert technical assistance. This work was supported by the Canadian Institutes of Health Research (PGT 162462 & 155961 ) and the Heart and Stroke Foundation of Canada ( G-19–0026260 ). SHM is supported by the Nova Scotia Health Research Foundation’s Scotia Scholars Award , a Level II Killam Predoctoral Scholarship, the Dalhousie Medical Research Foundation’s MacDonald Graduate Studentship , the Canadian Institutes of Health Research Doctoral Research Award , and Dalhousie University’s President’s Award . SB is supported by the Dalhousie Medical Research Foundation’s MacDonald Graduate Studentship, the Dalhousie Faculty of Medicine Graduate Studentship Award , and Heart and Stroke Canada’s Bright Red Award .

Publisher Copyright:
© 2022 The Authors

ASJC Scopus Subject Areas

Ageing
Developmental Biology

PubMed: MeSH publication types

Journal Article
Research Support, Non-U.S. Gov't

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.mad.2022.111638

Cite this

@article{b92e04b645db4b6eb4e14272ad5e6860,

title = "Serum testosterone concentrations are not associated with frailty in naturally ageing and testosterone-deficient older C57Bl/6 mice",

abstract = "This study investigated how serum testosterone related to frailty in ageing male C57Bl/6 mice with or without lifelong testosterone deficiency. Mice underwent a sham surgery (n = 10) or gonadectomy (n = 11, GDX) at 4-weeks and then aged. Frailty scores (31-item frailty index) and testosterone were measured between 18- to 24-months of age. Age predicted frailty (p < 0.0001), but serum testosterone did not (p = 0.357). Life expectancy (AFRAID clock) and biologic age (FRIGHT clock) were not significantly different between groups (p = 0.485 and 0.142). The fact that lifelong testosterone deficiency did not exacerbate frailty suggests that low testosterone alone does not potently drive frailty in males.",

author = "Heinze-Milne, {Stefan D.} and Shubham Banga and Judith Godin and Howlett, {Susan E.}",

note = "Funding Information: The authors thank Peter Nicholl for his expert technical assistance. This work was supported by the Canadian Institutes of Health Research (PGT 162462 & 155961 ) and the Heart and Stroke Foundation of Canada ( G-19–0026260 ). SHM is supported by the Nova Scotia Health Research Foundation{\textquoteright}s Scotia Scholars Award , a Level II Killam Predoctoral Scholarship, the Dalhousie Medical Research Foundation{\textquoteright}s MacDonald Graduate Studentship , the Canadian Institutes of Health Research Doctoral Research Award , and Dalhousie University{\textquoteright}s President{\textquoteright}s Award . SB is supported by the Dalhousie Medical Research Foundation{\textquoteright}s MacDonald Graduate Studentship, the Dalhousie Faculty of Medicine Graduate Studentship Award , and Heart and Stroke Canada{\textquoteright}s Bright Red Award . Publisher Copyright: {\textcopyright} 2022 The Authors",

year = "2022",

month = apr,

doi = "10.1016/j.mad.2022.111638",

language = "English",

volume = "203",

journal = "Mechanisms of Ageing and Development",

issn = "0047-6374",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Serum testosterone concentrations are not associated with frailty in naturally ageing and testosterone-deficient older C57Bl/6 mice

AU - Heinze-Milne, Stefan D.

AU - Banga, Shubham

AU - Godin, Judith

AU - Howlett, Susan E.

N1 - Funding Information: The authors thank Peter Nicholl for his expert technical assistance. This work was supported by the Canadian Institutes of Health Research (PGT 162462 & 155961 ) and the Heart and Stroke Foundation of Canada ( G-19–0026260 ). SHM is supported by the Nova Scotia Health Research Foundation’s Scotia Scholars Award , a Level II Killam Predoctoral Scholarship, the Dalhousie Medical Research Foundation’s MacDonald Graduate Studentship , the Canadian Institutes of Health Research Doctoral Research Award , and Dalhousie University’s President’s Award . SB is supported by the Dalhousie Medical Research Foundation’s MacDonald Graduate Studentship, the Dalhousie Faculty of Medicine Graduate Studentship Award , and Heart and Stroke Canada’s Bright Red Award . Publisher Copyright: © 2022 The Authors

PY - 2022/4

Y1 - 2022/4

N2 - This study investigated how serum testosterone related to frailty in ageing male C57Bl/6 mice with or without lifelong testosterone deficiency. Mice underwent a sham surgery (n = 10) or gonadectomy (n = 11, GDX) at 4-weeks and then aged. Frailty scores (31-item frailty index) and testosterone were measured between 18- to 24-months of age. Age predicted frailty (p < 0.0001), but serum testosterone did not (p = 0.357). Life expectancy (AFRAID clock) and biologic age (FRIGHT clock) were not significantly different between groups (p = 0.485 and 0.142). The fact that lifelong testosterone deficiency did not exacerbate frailty suggests that low testosterone alone does not potently drive frailty in males.

AB - This study investigated how serum testosterone related to frailty in ageing male C57Bl/6 mice with or without lifelong testosterone deficiency. Mice underwent a sham surgery (n = 10) or gonadectomy (n = 11, GDX) at 4-weeks and then aged. Frailty scores (31-item frailty index) and testosterone were measured between 18- to 24-months of age. Age predicted frailty (p < 0.0001), but serum testosterone did not (p = 0.357). Life expectancy (AFRAID clock) and biologic age (FRIGHT clock) were not significantly different between groups (p = 0.485 and 0.142). The fact that lifelong testosterone deficiency did not exacerbate frailty suggests that low testosterone alone does not potently drive frailty in males.

UR - http://www.scopus.com/inward/record.url?scp=85124134440&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85124134440&partnerID=8YFLogxK

U2 - 10.1016/j.mad.2022.111638

DO - 10.1016/j.mad.2022.111638

M3 - Article

C2 - 35124093

AN - SCOPUS:85124134440

SN - 0047-6374

VL - 203

JO - Mechanisms of Ageing and Development

JF - Mechanisms of Ageing and Development

M1 - 111638

ER -

Serum testosterone concentrations are not associated with frailty in naturally ageing and testosterone-deficient older C57Bl/6 mice

Abstract

Bibliographical note

ASJC Scopus Subject Areas

PubMed: MeSH publication types

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this